Clinical trial
Effect of Ascorbic Acid on the Incidence of Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
NCT01580683 is registered in ClinicalTrials.gov with Regional Hospital of Scranton as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Ascorbic Acid on the Incidence of Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
- Lead sponsor
- Regional Hospital of Scranton
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- July 31, 2012
- Completion date
- August 31, 2015
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.